References
- Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–867.
- Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010;140:900–917.
- Yang L, Li P, Fu S, et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 2010;11:467–478.
- Fésüs L, Demény MÁ, Petrovski G. Autophagy shapes inflammation. Antioxid Redox Signal 2011;14:2233–2243.
- Jones SA, Mills KH, Harris J. Autophagy and inflammatory diseases. Immunol Cell Biol 2013;91:250–258.
- Ellington AA, Berhow MA, Singletary KW. Inhibition of Akt signaling and enhanced ERK1/2 activity are involved in induction of macroautophagy by triterpenoid B-group soyasaponins in colon cancer cells. Carcinogenesis 2006;27:298–306.
- Mammucari C, Milan G, Romanello V, et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007;6:458–471.
- Xie Z, Klionsky DJ. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007;9:1102–1109.
- Stienstra R, Tack CJ, Kanneganti TD, et al. The inflammasome puts obesity in the danger zone. Cell Metab 2012;15:10–18.
- Yan Y, Jiang W, Spinetti T, et al. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 2013;38:1154–1163.
- Legrand-Poels S, Esser N, L’Homme L, et al. Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes. Biochem Pharmacol 2014;92:131–141.
- Williams-Bey Y, Boularan C, Vural A, et al. Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-κB activation and enhancing autophagy. PLoS One 2014;9:e97957.
- Shi CS, Shenderov K, Huang NN, et al. Activation of autophagy by inflammatory signals limits IL-1β production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012;13:255–263.
- Rovito D, Giordano C, Vizza D, et al. Omega-3 PUFA ethanolamides DHEA and EPEA induce autophagy through PPARγ activation in MCF-7 breast cancer cells. J Cell Physiol 2013;228:1314–1322.
- Rovito D, Giordano C, Plastina P, et al. Omega-3 DHA- and EPA-dopamine conjugates induce PPARγ-dependent breast cancer cell death through autophagy and apoptosis. Biochim Biophys Acta 2015;1850:2185–2195.
- Li P, Li YL, Li ZY, et al. Cross talk between vascular smooth muscle cells and monocytes through interleukin-1β/interleukin-18 signaling promotes vein graft thickening. Arterioscler Thromb Vasc Biol 2014;34:2001–2011.
- Mii S, Yamaoka T, Eguchi D, et al. Perioperative use of eicosapentaenoic acid and patency of infrainguinal vein bypass: a retrospective chart review. Curr Ther Res Clin Exp 2007;68:161–174.
- DiNicolantonio JJ, Niazi AK, McCarty MF, et al. Omega-3s and cardiovascular health. Ochsner J 2014;14:399–412.
- Laplante M, Sabatini DM. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 2013;126:1713–1719.
- NORMA Oficial Mexicana NOM-062-ZOO-1999, Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio. Available from: http://www.fmvz. unam.mx/fmvz/principal/archivos/062ZOO.PDF [Accessed 30 November 2015].
- Estadella D, da Penha Oller do Nascimento CM, Oyama LM, et al. Lipotoxicity: effects of dietary saturated and transfatty acids. Mediators Inflamm 2013;2013:137579. doi: 10.1155/2013/137579.
- Miller A, Adeli K. Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 2008;24:204–209.
- Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 2013;19:1166–1172.
- Bergheim I, Weber S, Vos M, et al. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J Hepatol 2008;48:983–992.
- Laugerette F, Vors C, Peretti N, Michalski MC. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie 2011;93:39–45.
- Dasilva G, Pazos M, García-Egido E, et al. Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: lipidomic biomarkers of oxidative stress and inflammation. J Nutr Biochem 2015; pii: S0955-2863(15)00163-1.
- Lamkanfi M. Emerging inflammasome effector mechanisms. Nat Rev Immunol 2011;11:213–220.
- Saitoh T, Fujita N, Jang MH, et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008;456:264–268.
- Shi CS, Shenderov K, Huang N, et al. Activation of autophagy by inflammatory signals limits IL-1b production by targeting ubiquitinated inflammasomes for destruction. Nature Immunol 2012;13:255–264.
- Zhou R, Yazdi A, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011;469:221–225.
- Nakahira K, Haspel JA, Rathinam V, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011;12:222–230.
- Amir M, Czaja MJ. Autophagy in nonalcoholic steatohepatitis. Expert Rev Gastroenterol Hepatol 2011;5:159–166.
- Mehal WZ. The inflammasome in liver injury and non-alcoholic fatty liver disease. Dig Dis 2014;32:507–515.
- Shin S, Jing K, Jeong S, et al. The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53. Biomed Res Int 2013:568671. doi: 10.1155/2013/568671.
- Jing K, Song KS, Shin S, et al. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy 2011;7:1348–1358.
- Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol 2009;183:787–791.
- Csak T, Ganz M, Pespisa J, et al. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology 2011;54:133–144.
- Ganz M, Csak T, Szabo G, et al. High fat diet feeding results in gender specific steatohepatitis and inflammasome activation. World J Gastroenterol 2014;20:8525–8534.
- Sanches SC, Ramalho LN, Augusto MJ, et al. Nonalcoholic steatohepatitis: a search for factual animal models. Biomed Res Int 2015;2015:574832.
- Ganz M, Bukong TN, Csak T, et al. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. J Transl Med 2015;13:193.
- Vyleta ML, Wong J, Magun BE. Suppression of ribosomal function triggers innate immune signaling through activation of the NLRP3 inflammasome. PLoS One 2012;7:e36044.
- Lu B, et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 2012;488:670–674.
- He Y, Franchi L, Nunez G. The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages. Eur. J. Immunol 2013;43:1147–1152.
- Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol 2013;13:397–411.
- Arshad MI, Piquet-Pellorce C, Samson M. IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology. Liver Int 2012;32:1200–1210.
- Jeftic I, Jovicic N, Pantic J, et al. Galectin-3 ablation enhances liver steatosis, but attenuates inflammation and IL-33 dependent fibrosis in obesogenic mouse model of nonalcoholic steatohepatitis. Mol Med 2015;21:453--465.
- Salmond RJ1, Mirchandani AS, Besnard AG, et al. IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin. J Allergy Clin Immunol 2012;130:1159–1166.e6.
- Delerive P, De Bosscher K, Besnard S, et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 1999;274:32048–32054.
- Zúñiga J, Cancino M, Medina F, et al. N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS One 2011;6:e28502.
- Nath B, Levin I, Csak T, et al. Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 2011;53:1526–1537.
- Burgueno AL, Fernandez GT, Gonzales MN, et al. Cardiovascular disease is associated with high fat diet-induced liver damage and upregulation of hepatic expression of hypoxia-inducible factor 1 alpha in a rat model. Clin Sci (Lond) 2013;124:53–63.
- Mejía-Barradas CM, Del-Río-Navarro BE, Domínguez-López A, et al. The consumption of n-3 polyunsaturated fatty acids differentially modulates gene expression of peroxisome proliferator-activated receptor alpha and gamma and hypoxia-inducible factor 1 alpha in subcutaneous adipose tissue of obese adolescents. Endocrine 2014;45:98–105.
- Düvel K, Yecies JL, Menon S, et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol Cell 2010;39:171–183.
- Srivastava RA, Pinkosky SL, Filippov S, et al. AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseases. J Lipid Res 2012;53:2490–2514.
- Jump DB. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr Opin Lipidol 2008;19:242–247.
- Srivastava RA, He S. Anti-hyperlipidemic and insulin sensitizing activities of fenofibrate reduces aortic lipid deposition in hyperlipidemic Golden Syrian hamster. Mol Cell Biochem 2010;345:197–206.
- Haas JT1, Miao J, Chanda D, et al. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab 2012;15:873–884.
- Buettner R, Parhofer KG, Woenckhaus M, et al. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol 2006;36:485–501.
- Liu X, Xue Y, Liu C, et al. Eicosapentaenoic acid-enriched phospholipid ameliorates insulin resistance and lipid metabolism in diet-induced-obese mice. Lipids Health Dis 2013;12:109.
- Peterson TR, Sengupta SS, Harris TE, et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011;146:408–420.
- Souza-Mello V. Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. World J Hepatol 2015;7:1012–1019.
- Karsenty J, Landrier JF, Rousseau-Ralliard D, et al. Beneficial effects of omega-3 fatty acids on the consequences of a fructose diet are not mediated by PPAR delta or PGC1 alpha. Eur J Nutr 2013;52:1865–1874.
- Feillet-Coudray C, Aoun M, Fouret G, et al. Effects of long-term administration of saturated and n-3 fatty acid-rich diets on lipid utilisation and oxidative stress in rat liver and muscle tissues. Br J Nutr 2013;110:1789–1802.
- Bonilla S, Redonnet A, Noël-Suberville C, et al. High-fat diets affect the expression of nuclear retinoic acid receptor in rat liver. Br J Nutr 2000;83:665–671.
- Dong B, Kan CF, Singh AB, Liu J. High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway. J Lipid Res 2013;54:1241–1254.
- Mori T, Kondo H, Hase T, Murase T. Dietary phospholipids ameliorate fructose-induced hepatic lipid and metabolic abnormalities in rats. J Nutr 2011;141:2003–2009.
- Kim JK, Lee KS, Chang HY, et al. Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of Kruppel-like-factor 10 in mice. J Transl Med 2014;12:186.
- Xu J, Christian B, Jump DB. Regulation of rat hepatic l-pyruvate kinase promoter composition and activity by glucose, n-3 polyunsaturated fatty acids, and peroxisome proliferator-activated receptor-α agonist. J Biol Chem 2006;281:18351–18362.
- Benhamed F, Denechaud PD, Lemoine M, et al. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest 2012;122:2176–2194.
- Ghoneim RH, Ngo Sock ET, Lavoie JM, Piquette-Miller M. Effect of a high-fat diet on the hepatic expression of nuclear receptors and their target genes: relevance to drug disposition. Br J Nutr 2015;113:507–516.
- Kasbi Chadli F, Nazih H, Krempf M, et al. Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet. PLoS One 2013;8:e61109.
- Wang Y, Botolin D, Xu J, et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J Lipid Res 2006;47:2028–2041.
- Tripathy S, Lytle KA, Stevens RD, et al. Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL/6J mice. J Lipid Res 2014;55:1448–1464.
- Tripathy S, Torres-Gonzalez M, Jump DB. Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL/6J mice. J Lipid Res 2010;51:2642–2654.
- Wang Y, Botolin D, Christian B, et al. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J Lipid Res 2005;46:706–715.
- Matsuzaka T, Atsumi A, Matsumori R, et al. Elovl6 promotes nonalcoholic steatohepatitis. Hepatology 2012;56:2199–2208.
- Muir K, Hazim A, He Y, et al. Proteomic and lipidomic signatures of lipid metabolism in NASH-associated hepatocellular carcinoma. Cancer Res 2013;73:4722–4731.
- Kessler SM, Laggai S, Barghash A, et al. Lipid metabolism signatures in NASH-associated HCC. Cancer Res 2014;74:2903–2904.
- Dowman JK, Hopkins LJ, Reynolds GM, et al. Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle. Am J Pathol 2014;184:1550–1561.
- Brown JM, Chung S, Sawyer JK, et al. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2010;30:24–30.
- Fernández Gianotti T, Burgueño A, Gonzales Mansilla N, et al. Fatty liver is associated with transcriptional downregulation of stearoyl-CoA desaturase and impaired protein dimerization. PLoS One 2013;8:e76912.
- Biddinger SB, Almind K, Miyazaki M, et al. Effects of diet and genetic background on sterol regulatory element-binding protein-1c, stearoyl-CoA desaturase 1, and the development of the metabolic syndrome. Diabetes 2005;54:1314–1323.
- Waters KM, Ntambi JM. Insulin and dietary fructose induce stearoyl-CoA desaturase 1 gene expression of diabetic mice. J Biol Chem 1994;269:27773–27777.
- Hofacer R, Magrisso IJ, Jandacek R, et al. Omega-3 fatty acid deficiency increases stearoyl-CoA desaturase expression and activity indices in rat liver: positive association with non-fasting plasma triglyceride levels. Prostaglandins Leukot Essent Fatty Acids 2012;86:71–77.
- Liu X, Gao Y, Li M, et al. Sirt1 mediates the effect of the heme oxygenase inducer, cobalt protoporphyrin, on ameliorating liver metabolic damage caused by a high-fat diet. J Hepatol 2015;63:713–721.
- Xue B, Yang Z, Wang X, Shi H. Omega-3 polyunsaturated fatty acids antagonize macrophage inflammation via activation of AMPK/SIRT1 pathway. PLoS One 2012;7:e45990012; doi: 10.1371/journal.pone.0045990.